intrauterine pregnancies but has little or no effect on the incidence of ectopic pregnancies, and therefore the total number of such pregnancies observed is roughly equal to what would be expected if no contraception had been used.
In the past three years we have treated 715 cases with the Yuzpe regimen and had 17 failures, including the present case of an ectopic pregnancy. This rate is compatible with the calculated risk of 1000 for ectopic pregnancies. 4 We believe that this is the first reported case of an ectopic pregnancy after the Yuzpe regimen. We suggest that patients requesting postcoital treatment should be counselled about this rare but serious complication and warned of the need for prompt examination if they develop severe pelvic pain. Until more evidence is available about the presence or absence of a causative relation between postcoital hormonal treatment and ectopic pregnancies, the history of previous tubal pregnancy would be a strong contraindication to postcoital treatment. A careful vaginal examination at the follow up visit is important, as vaginal bleeding associated with an ectopic pregnancy can be so easily mistaken for a period, as in our patient. On examination she was alert but had severe bilateral papilloedema. Visual acuity was 6/6 bilaterally and the visual fields were normal. There were no other abnormal findings. A gammascan and computed tomography of the head yielded normal results. Lumbar puncture showed a cerebrospinal fluid pressure of 3-15 cmH2O, but further examination of the cerebrospinal fluid gave normal results. Left carotid arteriography showed superior sagittal sinus thrombosis with occlusion of the sinus at the vertex. Haemoglobin concentration was 13-9 g/dl and white cell count was 9 1 X 109/1 with a normal differential, but the platelet count was 748 x 109/1 and subsequently varied between this level and 934x 109/1. The erythrocyte sedimentation rate was 15 mm in the first hour. Total cellularity of the bone marrow was normal but there were increased numbers of megakaryocytes.
There was no cause for secondary thrombocytosis, and essential thrombocythaemia was diagnosed. Platelet aggregation in response to adenosine diphosphate, adrenaline, and collagen was normal. She underwent bilateral decompression of the optic nerve in October 1980 and was treated with hydroxyurea. The platelet count fell to within the normal range and her symptoms resolved, but mild papilloedema persisted.
CASE 2
In 1977 a 38 year old Iranian woman presented with visual obscurations. Examination showed bilateral papilloedema but no other abnormal physical signs. She had never taken the contraceptive pill. Cerebrospinal fluid tests, a gammascan, and serial computed tomography of the head over three years gave normal results. Benign intracranial hypertension was diagnosed. She was found to have thrombocytosis and was referred to this hospital. Her platelet count was 1326x 109/1. Haemoglobin concentration was 13-1 g/dl and white cell count 9 5X 109/1 (6°/ myelocytes, 1% metamyelocytes, 50" neutrophils, 35°' lymphocytes, 3°, eosinophils, 5%O monocytes). Total cellularity of the bone marrow was normal, but increased numbers of megakaryocytes were present. Essential thrombocythaemia was diagnosed. Platelet aggregation in response to adenosine diphosphate, adrenaiine, and collagen was normal. She was treated initially with pipobroman and subsequently with one dose of radioactive phosphorus. The thrombocytosis and her symptoms resolved. Mild papilloedema persisted for six years but otherwise she remained well.
Comment
Spontaneous thrombosis of the superior sagittal sinus is rare5 and may present as isolated papilloedema. The classic predisposing factors such as sepsis, malignancy, polycythaemia rubra vera, pregnancy, and the puerperium are often absent. This condition was demonstrated in one patient in this report and was strongly suspected in the other; both patients had essential thrombocythaemia. Anticoagulants were not used in either case because of the associated thrombocytosis. (600-700 mg) phosphorus a day. Dietary advice was reinforced at regular clinic visits, and adherence to the diet was assessed by a combination of dietary checks and measurement of ratios of urea to creatinine concentrations. The rate of progression of renal function before and during the diet was assessed by plotting the reciprocal of serum creatinine concentrations against time.3 Paired Student's t test was used for statistical analysis.
Full data were available on 31 patients (age range 17-65 (mean 47)), who were studied for three to 62 (mean 18) months and had a mean (SEM) serum creatinine concentration of 819 (45) ttmol/l (9 3 (0-5) mg/100 ml) and a mean serum urea concentration of 37 (2) mmol/l (222 (12) mg/100 ml) at the start of dietary treatment. Mean serum phosphate concentrations remained stable at 2 17 (0 12) mmol/l (6-7 (0 4) mg/100 ml) before the diet and 1 95 (0 08) mmol/l (6-0 (0 2) mg/100 ml) during the diet.
For the whole group there was a highly significant (p< 0 001) change in the slopes showing progression of disease from ---1-17 (0-17) (X 10-4) before the diet to -0 5 (0-11) (x 10-4) during the diet. Twenty seven patients responded to dietary treatment, as shown by a change in the angle of the slope. The figure shows individual progression slopes for those who responded according to the serum creatinine concentrations at the start of the diet and for those who did not respond. There was also a highly significant (p < 0-001) change in the mean ratio of urea to creatinine concentrations from 0 049 (0 002) before the diet to 0-041 (0-001) during the diet. Only one patient with proteinuria (>5 g/24 h) showed evidence of protein depletion with persistently reduced total serum protein and serum albumin concentrations. concentrations at the start of the diet: (a) initial concentration < 650 ,/mol/l (7.4 mg/100 ml); (b) initial concentration < 850 ,umol/l (9.7 mg/100 ml); (c) initial concentration ;851 ,umol/I (9.7 mg/100 ml).
This study shows that deterioration in renal function can be slowed significantly by a diet containing 35-45 g protein, which is double the amount allowed in a previous diet.4 The exact mechanism of the effect has not been determined and may depend on several factors including control of blood pressure and serum phosphate concentrations.'
There are no recent guidelines on when to restrict protein intake in chronic renal failure, although the onset of uraemic symptomns used to be a criterion. Our data (figure) suggest that dietary modifications should be introduced early-that is, when serum creatinine concentrations are less than 650 4mol/l (7 4 mg/100 ml)-to obtain maximum response. Some patients were given a long time (up to several years) free from dialysis. It has never been claimed that a low protein diet should be a substitute for efficient dialysis when that is indicated. Dietary modification early in the course of chronic renal failure, however, can delay the start of dialysis, thereby allowing more efficient use of existing dialysis facilities.
As we had sufficient data for fewer than half the patients treated further controlled studies of the role of dietary protein are required to ascertain the best method of treatment and to avoid protein malnutrition. The study highlights the need for early patient referral to specialist renal units to obtain maximum benefits from dietary modifications. 
The low prevalence in Dublin, situated so close to Britain, is remarkable. It is difficult to reconcile with the recent hypothesis that the disease is due to infection with a virus,9 since the virus must be
